Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Kosan receives NIH grant for macrolide antibiotic development

Sep. 9, 1997

Anti-HSV compounds with a novel mechanism of action

Sep. 8, 1997

SmithKline Beecham synthesizes mechanism-based HSV protease inhibitors

Sep. 5, 1997

Leucomycin analogues reported by Meiji Seika

Sep. 3, 1997

Carbohydrate-based antimicrobial agents from Novo Nordisk

Sep. 3, 1997

Novel antimicrobial agents discovered by Ortho

Sep. 2, 1997

FDA approves Gensia's injectable acyclovir

Aug. 29, 1997

Faulding's generic acyclovir receives FDA approval

Aug. 29, 1997

Marketing agreement reached for Abelcet in France and Italy

Aug. 28, 1997

BMS reports new cephalosporins active against MRSA

Aug. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...